Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017105
Sloan Kettering Institute
Search grants from Sloan Kettering Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Insulin Modulates Parasympathetic Nerve Control of Lungs
Informatics Tools for Optimized Imaging Biomarkers for Cancer Research&Discovery
B Cell Signaling
Evolutionary Algorithm for Protein Structure Prediction
Development and Regulation of Natural Killer Cells
Recently added grants:
Identification of genetic and environmental suppressors of mitochondrial dysfunction
Development and application of new tools to identify repeat expansions in human diseases
Role of Kdm5c dosage in mouse neural development
Role of SCGN in Intestinal Immune Homeostasis
Interactions of Environmental Chemical Mixtures, Genetics, and Immune Pathways in Autism Spectrum Disorder
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017105-002
Application #
6688654
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Sloan Kettering Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
Comments
Be the first to comment on this grant